ATC code L01 Antineoplastic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L01 is part of the anatomical group L Antineoplastic and immunomodulating agents.
Contents
- L01AA Nitrogen mustard analogues
- L01AB Alkyl sulfonates
- L01AC Ethylene imines
- L01AD Nitrosoureas
- L01AG Epoxides
- L01AX Other alkylating agents
- L01BA Folic acid analogues
- L01BB Purine analogues
- L01BC Pyrimidine analogues
- L01CA Vinca alkaloids and analogues
- L01CB Podophyllotoxin derivatives
- L01CC Colchicine derivatives
- L01CD Taxanes
- L01CX Other plant alkaloids and natural products
- L01DA Actinomycines
- L01DB Anthracyclines and related substances
- L01DC Other cytotoxic antibiotics
- L01XA Platinum compounds
- L01XB Methylhydrazines
- L01XC Monoclonal antibodies
- L01XD Sensitizers used in photodynamicradiation therapy
- L01XE Protein kinase inhibitors
- L01XX Other antineoplastic agents
- References
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL01. ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
L01AA Nitrogen mustard analogues
L01AA01 CyclophosphamideL01AA02 ChlorambucilL01AA03 MelphalanL01AA05 ChlormethineL01AA06 IfosfamideL01AA07 TrofosfamideL01AA08 PrednimustineL01AA09 BendamustineL01AB Alkyl sulfonates
L01AB01 BusulfanL01AB02 TreosulfanL01AB03 MannosulfanL01AC Ethylene imines
L01AC01 ThiotepaL01AC02 TriaziquoneL01AC03 CarboquoneL01AD Nitrosoureas
L01AD01 CarmustineL01AD02 LomustineL01AD03 SemustineL01AD04 StreptozocinL01AD05 FotemustineL01AD06 NimustineL01AD07 RanimustineL01AG Epoxides
L01AG01 EtoglucidL01AX Other alkylating agents
L01AX01 MitobronitolL01AX02 PipobromanL01AX03 TemozolomideL01AX04 DacarbazineL01BA Folic acid analogues
L01BA01 MethotrexateL01BA03 RaltitrexedL01BA04 PemetrexedL01BA05 PralatrexateL01BB Purine analogues
L01BB02 MercaptopurineL01BB03 TioguanineL01BB04 CladribineL01BB05 FludarabineL01BB06 ClofarabineL01BB07 NelarabineL01BC Pyrimidine analogues
L01BC01 CytarabineL01BC02 FluorouracilL01BC03 TegafurL01BC04 CarmofurL01BC05 GemcitabineL01BC06 CapecitabineL01BC07 AzacitidineL01BC08 DecitabineL01BC52 Fluorouracil, combinationsL01BC53 Tegafur, combinationsL01BC59 Trifluridine, combinationsL01CA Vinca alkaloids and analogues
L01CA01 VinblastineL01CA02 VincristineL01CA03 VindesineL01CA04 VinorelbineL01CA05 VinflunineL01CA06 VintafolideL01CB Podophyllotoxin derivatives
L01CB01 EtoposideL01CB02 TeniposideL01CC Colchicine derivatives
L01CC01 DemecolcineL01CD Taxanes
L01CD01 PaclitaxelL01CD02 DocetaxelL01CD03 Paclitaxel poliglumexL01CD04 CabazitaxelL01CX Other plant alkaloids and natural products
L01CX01 TrabectedinL01DA Actinomycines
L01DA01 DactinomycinL01DB Anthracyclines and related substances
L01DB01 DoxorubicinL01DB02 DaunorubicinL01DB03 EpirubicinL01DB04 AclarubicinL01DB05 ZorubicinL01DB06 IdarubicinL01DB07 MitoxantroneL01DB08 PirarubicinL01DB09 ValrubicinL01DB10 AmrubicinL01DB11 PixantroneL01DC Other cytotoxic antibiotics
L01DC01 BleomycinL01DC02 PlicamycinL01DC03 MitomycinL01DC04 IxabepiloneL01XA Platinum compounds
L01XA01 CisplatinL01XA02 CarboplatinL01XA03 OxaliplatinL01XA04 SatraplatinL01XA05 PolyplatillenL01XB Methylhydrazines
L01XB01 ProcarbazineL01XC Monoclonal antibodies
L01XC01 EdrecolomabL01XC02 RituximabL01XC03 TrastuzumabL01XC05 GemtuzumabL01XC06 CetuximabL01XC07 BevacizumabL01XC08 PanitumumabL01XC09 CatumaxomabL01XC10 OfatumumabL01XC11 IpilimumabL01XC12 Brentuximab vedotinL01XC13 PertuzumabL01XC14 Trastuzumab emtansineL01XC15 ObinutuzumabL01XC16 DinutuximabL01XC17 NivolumabL01XC18 PembrolizumabL01XC19 BlinatumomabL01XC21 RamucirumabL01XC22 NecitumumabL01XC23 ElotuzumabL01XC24 DaratumumabL01XC25 MogamulizumabL01XC26 Inotuzumab ozogamicinL01XD Sensitizers used in photodynamic/radiation therapy
L01XD01 Porfimer sodiumL01XD03 Methyl aminolevulinateL01XD04 Aminolevulinic acidL01XD05 TemoporfinL01XD06 EfaproxiralL01XE Protein kinase inhibitors
L01XE01 ImatinibL01XE02 GefitinibL01XE03 ErlotinibL01XE04 SunitinibL01XE05 SorafenibL01XE06 DasatinibL01XE07 LapatinibL01XE08 NilotinibL01XE09 TemsirolimusL01XE10 EverolimusL01XE11 PazopanibL01XE12 VandetanibL01XE13 AfatinibL01XE14 BosutinibL01XE15 VemurafenibL01XE16 CrizotinibL01XE17 AxitinibL01XE18 RuxolitinibL01XE19 RidaforolimusL01XE21 RegorafenibL01XE22 MasitinibL01XE23 DabrafenibL01XE24 PonatinibL01XE25 TrametinibL01XE26 CabozantinibL01XE27 IbrutinibL01XE28 CeritinibL01XE29 LenvatinibL01XE31 NintedanibL01XE32 CediranibL01XE33 PalbociclibL01XE34 TivozanibL01XE35 OsimertinibL01XE36 AlectinibL01XE37 RociletinibL01XE38 CobimetinibL01XE39 MidostaurinL01XE40 OlmutinibQL01XE91 ToceranibL01XX Other antineoplastic agents
L01XX01 AmsacrineL01XX02 AsparaginaseL01XX03 AltretamineL01XX05 HydroxycarbamideL01XX07 LonidamineL01XX08 PentostatinL01XX09 MiltefosineL01XX10 MasoprocolL01XX11 EstramustineL01XX14 TretinoinL01XX16 MitoguazoneL01XX17 TopotecanL01XX18 TiazofurineL01XX19 IrinotecanL01XX22 AlitretinoinL01XX23 MitotaneL01XX24 PegaspargaseL01XX25 BexaroteneL01XX27 Arsenic trioxideL01XX29 Denileukin diftitoxL01XX32 BortezomibL01XX33 CelecoxibL01XX35 AnagrelideL01XX36 OblimersenL01XX37 Sitimagene ceradenovecL01XX38 VorinostatL01XX39 RomidepsinL01XX40 Omacetaxine mepesuccinateL01XX41 EribulinL01XX42 PanobinostatL01XX43 VismodegibL01XX44 AfliberceptL01XX45 CarfilzomibL01XX46 OlaparibL01XX47 IdelalisibL01XX48 SonidegibL01XX49 BelinostatL01XX50 IxazomibL01XX51 Talimogene laherparepvecL01XX52 VenetoclaxL01XX53 VosaroxinReferences
ATC code L01 Wikipedia(Text) CC BY-SA